Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
OverviewDNA damaging chemotherapy is the first line of treatment for certain cancers, but its longterm success is often marred by the eventual acquisition of chemoresistance.Other cancers cannot be treated because they are intrinsically resistant to such chemotherapy.These 2 types of resistance are coupled in the context of translesion synthesis (TLS), which is carried out by specialized TLS DNA polymerases that can replicate past DNA lesions but in a lower fidelity manner.First, TLS DNA polymerases permit the bypass of modified DNA bases during DNA synthesis, thereby allowing proliferation to continue in the presence of chemotherapy, an issue of particular relevance to intrinsic drug resistance.Second, mistakes introduced by TLS polymerases copying over DNA lesions introduced during the chemotherapy lead to mutations that contribute to acquired resistance.These dual functions of mutagenic TLS polymerases with respect to chemoresistance make these proteins very promising targets for adjuvant therapy.The major branch of mutagenic TLS requires REV1, a Y family DNA polymerase that recruits other TLS polymerases with its C-terminal domain (CTD) including POL z, which is also required.Recent evidence obtained using mouse models is summarized, which shows that interfering with REV1/POL z-dependent mutagenic TLS during DNA damaging chemotherapy can help overcome problems due to both intrinsic resistance and acquired resistance.Ways to develop drugs that block mutagenic TLS are also considered, including taking advantage of structural knowledge to target key protein-protein interfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because TLS events may protect tumor cells by favoring DNA replication”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [108]
In the citing paper
“TLS is considered a potential target in cancer therapy [98,108,109]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [108]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krokan, H. E., & Bjoras, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012583 · Cited by 1,322
The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η
Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., & Hanaoka, F. (1999) · Nature · doi:10.1038/21447 · Cited by 1,292 · cited 3×
“Pamoic acid, aurintricarboxylic acid, and ellagic acid were found to inhibit POL ι and POL η [112], while candesartan cilexetil inhibited the enzymatic function of POL κ as well as enhanced UV-induced cytotoxicity in xeroderma pigmentosum-variant (XP-V) cells [116].”
BackgroundInfluentialNucleotide Excision Repair in Eukaryotes
Scharer, O. D. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012609 · Cited by 801
Stromal biology and therapy in pancreatic cancer
Neesse, A., Michl, P., Frese, K. K., Feig, C., Cook, N., Jacobetz, M. A., Lolkema, M. P., Buchholz, M., Olive, K. P., Gress, T. M., et al. (2011) · Gut · doi:10.1136/gut.2010.226092 · Cited by 757 · cited 1×
“Many tumors, including most pancreatic adenocarcinomas, nonsmall cell lung cancers, and aggressive brain tumors, as well as most metastatic malignancies, fail to significantly regress following chemotherapy [2].”
BackgroundInfluentialY-family DNA polymerases and their role in tolerance of cellular DNA damage
Sale, J. E., Lehmann, A. R., & Woodgate, R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3289 · Cited by 665 · cited 2×
“REV1 functions as a principle scaffolding protein, which recruits other TLS polymerases to first insert a nucleotide opposite the DNA lesion and then eventually help extend the distorted primer-template terminus, in what is recognized as the two-step mechanism of TLS (Fig 2) [7, 8, 89].”
BackgroundMechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660 · cited 1×
“This can include the activation of drug efflux pumps or detoxifying processes that effectively reduce intracellular drug concentration [1].”
BackgroundEukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions
Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., & Prakash, L. (2000) · Nature · doi:10.1038/35023030 · Cited by 632 · cited 2×
“POL ζ4 B-family (REV3 [REV3] polymerase, REV7 [REV7], POLD2 and POLD3 accessory subunits) [65] • POL ζ4 mediate inefficient TLS across CPDs, (6–4) photoproducts, adducted residues and AP sites, but an error free bypass of thymine glycols [53, 66, 67] • Serves as the key extender polymerase during TLS [68] • REV3 prote…”
BackgroundREV7 counteracts DNA double-strand break resection and affects PARP inhibition
Xu, G., Chapman, J. R., Brandsma, I., Yuan, J., Mistrik, M., Bouwman, P., Bartkova, J., Gogola, E., Warmerdam, D., Barazas, M., et al. (2015) · Nature · doi:10.1038/nature14328 · Cited by 593
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Waters, L. S., Minesinger, B. K., Wiltrout, M. E., D'Souza, S., Woodruff, R. V., & Walker, G. C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00034-08 · Cited by 591 · cited 2×
“REV1 functions as a principle scaffolding protein, which recruits other TLS polymerases to first insert a nucleotide opposite the DNA lesion and then eventually help extend the distorted primer-template terminus, in what is recognized as the two-step mechanism of TLS (Fig 2) [7, 8, 89].”
BackgroundSelf-citationDeoxycytidyl transferase activity of yeast REV1 protein
Nelson, J. R., Lawrence, C. W., & Hinkle, D. C. (1996) · Nature · doi:10.1038/382729a0 · Cited by 572 · cited 1×
“REV1 (REV1) Y-family • Exclusively inserts dCMPs opposite template Gs, abasic sites, and adducted G residues [13, 14] • Acts as a scaffolding protein by interacting with both POL ζ and RIR containing POL η, POL κ and POL ι [15, 16] • Generates G/C substitutions during Ig gene somatic hypermutation [17] • Accumulates i…”
BackgroundMechanism of Replication-Coupled DNA Interstrand Crosslink Repair
Räschle, M., Knipscheer, P., Enoiu, M., Angelov, T., Sun, J., Griffith, J. D., Ellenberger, T. E., Schärer, O. D., & Walter, J. C. (2008) · Cell · doi:10.1016/j.cell.2008.08.030 · Cited by 511
Mechanisms of accurate translesion synthesis by human DNA polymerase η
Masutani, C., Kusumoto, R., Iwai, S., & Hanaoka, F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3100 · Cited by 504
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Lord, C. J., Tutt, A. N. J., & Ashworth, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022545 · Cited by 471
DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes
Zeng, X., Winter, D. B., Kasmer, C., Kraemer, K. H., Lehmann, A. R., & Gearhart, P. J. (2001) · Nature Immunology · doi:10.1038/88740 · Cited by 420 · cited 1×
“• Generates A/T substitutions during somatic hypermutagenesis [34] • Protein expression ubiquitous in nucleus and cytoplasm of all tissues, with high expression in thyroid, lung, pancreas, placenta, testis, etc.”
BackgroundWhat a difference a decade makes: Insights into translesion DNA synthesis
Yang, W., & Woodgate, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704219104 · Cited by 379 · cited 1×
“REV1 functions as a principle scaffolding protein, which recruits other TLS polymerases to first insert a nucleotide opposite the DNA lesion and then eventually help extend the distorted primer-template terminus, in what is recognized as the two-step mechanism of TLS (Fig 2) [7, 8, 89].”
BackgroundStructure of the Catalytic Core of S. cerevisiae DNA Polymerase η
Trincao, J., Johnson, R. E., Escalante, C. R., Prakash, S., Prakash, L., & Aggarwal, A. K. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00306-9 · Cited by 344
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
Self-citationGoodman, M. F., & Woodgate, R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a010363 · Cited by 317
Epigenetic Instability due to Defective Replication of Structured DNA
Sarkies, P., Reams, C., Simpson, L. J., & Sale, J. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.009 · Cited by 307
MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end resection
Boersma, V., Moatti, N., Segura-Bayona, S., Peuscher, M. H., van der Torre, J., Wevers, B. A., Orthwein, A., Durocher, D., & Jacobs, J. J. L. (2015) · Nature · doi:10.1038/nature14216 · Cited by 304
Golgher, D., Jones, E., Powrie, F., Elliott, T., & Gallimore, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3267::aid-immu3267>3.0.co;2-1 · Cited by 282
DNA Damage Response Genes and the Development of Cancer Metastasis
Broustas, C. G., & Lieberman, H. B. (2014) · Radiation Research · doi:10.1667/rr13515.1 · Cited by 275
Advances in Understanding the Complex Mechanisms of DNA Interstrand Cross-Link Repair
Clauson, C., Scharer, O. D., & Niedernhofer, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012732 · Cited by 246 · cited 1×
“Likewise, in nonreplicating cells, ICL repair depends on the Rev1-POL z TLS polymerases to fill the ssDNA-gaps [98].”
BackgroundHow DNA lesions are turned into mutations within cells?
Pagès, V., & Fuchs, R. P. (2002) · Oncogene · doi:10.1038/sj.onc.1206006 · Cited by 237
Dual Roles for DNA Polymerase η in Homologous DNA Recombination and Translesion DNA Synthesis
Kawamoto, T., Araki, K., Sonoda, E., Yamashita, Y. M., Harada, K., Kikuchi, K., Masutani, C., Hanaoka, F., Nozaki, K., Hashimoto, N., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.016 · Cited by 231
Human DNA Polymerase κ Encircles DNA: Implications for Mismatch Extension and Lesion Bypass
Lone, S., Townson, S. A., Uljon, S. N., Johnson, R. E., Brahma, A., Nair, D. T., Prakash, S., Prakash, L., & Aggarwal, A. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.018 · Cited by 225
Error-prone translesion synthesis mediates acquired chemoresistance
Xie, K., Doles, J., Hemann, M. T., & Walker, G. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011412107 · Cited by 219
Self-citation8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins
Maga, G., Villani, G., Crespan, E., Wimmer, U., Ferrari, E., Bertocci, B., & Hübscher, U. (2007) · Nature · doi:10.1038/nature05843 · Cited by 218
Replication of a cis–syn thymine dimer at atomic resolution
Ling, H., Boudsocq, F., Plosky, B. S., Woodgate, R., & Yang, W. (2003) · Nature · doi:10.1038/nature01919 · Cited by 216
Tissier, A., Kannouche, P., Reck, M.-P., Lehmann, A. R., Fuchs, R. P. P., & Cordonnier, A. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.06.015 · Cited by 207 · cited 1×
“POL η (POLH) Y-family • Bypasses T-T CPD and cisplatin-GG efficiently, but inefficiently across adducted residues, AP sites, 8-oxo-G [27–32] • Accumulates at DNA damage foci [20, 33].”
BackgroundMultiple roles of Rev3, the catalytic subunit of pol in maintaining genome stability in vertebrates
Sonoda, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg308 · Cited by 204
Jansen, J. G., Langerak, P., Tsaalbi-Shtylik, A., van den Berk, P., Jacobs, H., & de Wind, N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052227 · Cited by 203
Doles, J., Oliver, T. G., Cameron, E. R., Hsu, G., Jacks, T., Walker, G. C., & Hemann, M. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011409107 · Cited by 190
Self-citationKannouche, P., Fernández de Henestrosa, A. R., Coull, B., Vidal, A. E., Gray, C., Zicha, D., Woodgate, R., & Lehmann, A. R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf618 · Cited by 189 · cited 1×
“POL ι (POLI) Y-family • Efficiently bypasses template dA; but does so inefficiently on the template dT [52, 53] • Briefly accumulates in replication stress foci [54] • Back-up polymerase in the absence of POL η.”
BackgroundSrivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421365112 · Cited by 188 · cited 2×
“Likewise depletion of REV3 in cervical cancer cells [109] or nonsmall cell lung cancer cells [110]; REV1, POL z, POL η in HeLa cells [111]; and POL η in ovarian cancer stem cells [39] all sensitize cells to cisplatin.”
BackgroundMakarova, A. V., Stodola, J. L., & Burgers, P. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks948 · Cited by 183
Gibbs, P. E. M., McDonald, J., Woodgate, R., & Lawrence, C. W. (2005) · Genetics · doi:10.1534/genetics.104.034611 · Cited by 178
Simpson, L. J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg161 · Cited by 178 · cited 1×
“REV1 (REV1) Y-family • Exclusively inserts dCMPs opposite template Gs, abasic sites, and adducted G residues [13, 14] • Acts as a scaffolding protein by interacting with both POL ζ and RIR containing POL η, POL κ and POL ι [15, 16] • Generates G/C substitutions during Ig gene somatic hypermutation [17] • Accumulates i…”
BackgroundBartz, S. R., Zhang, Z., Burchard, J., Imakura, M., Martin, M., Palmieri, A., Needham, R., Guo, J., Gordon, M., Chung, N., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01229-06 · Cited by 177
Disruption of the developmentally regulated Rev3l gene causes embryonic lethality
Wittschieben, J., Shivji, M. K. K., Lalani, E., Jacobs, M. A., Marini, F., Gearhart, P. J., Rosewell, I., Stamp, G., & Wood, R. D. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00725-9 · Cited by 173
Waters, L. S., & Walker, G. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510167103 · Cited by 173 · cited 1×
“Apart from bypassing DNA damage at stalled replication forks, TLS polymerases also engage in filling single stranded (ss) DNA gaps left behind by replicative polymerases, via the less-well understood gap-filling mechanism [92, 93].”
BackgroundSelf-citationBemark, M., Khamlichi, A. A., Davies, S. L., & Neuberger, M. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00724-7 · Cited by 170
Human DINB1 -encoded DNA polymerase κ is a promiscuous extender of mispaired primer termini
Washington, M. T., Johnson, R. E., Prakash, L., & Prakash, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032594399 · Cited by 165
Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin
Zhao, Y., Biertümpfel, C., Gregory, M. T., Hua, Y.-J., Hanaoka, F., & Yang, W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202681109 · Cited by 160
Damage repair DNA polymerases Y
Yang, W. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00003-9 · Cited by 153 · cited 1×
“Together, these structural attributes result in a larger and/or more permissive catalytic site than replicative polymerases that allows TLS polymerases to accommodate distorted and damaged nucleotides [81, 82].”
BackgroundTranslesion Synthesis across Bulky N2-Alkyl Guanine DNA Adducts by Human DNA Polymerase κ
Choi, J., Angel, K. C., & Guengerich, F. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602246200 · Cited by 153 · cited 1×
“POL κ (POLK) Y-family • Propensity to make −1 frameshift mutations, but efficiently bypasses thymine glycols and guanine adducts [42, 43] • Propensity to extend mispaired primer-template termini [44] • Protein expression data in normal tissues unknown • RNA expressed in all tissues, with slightly high expression in th…”
BackgroundSakiyama, T., Kohno, T., Mimaki, S., Ohta, T., Yanagitani, N., Sobue, T., Kunitoh, H., Saito, R., Shimizu, K., Hirama, C., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20790 · Cited by 146
Sakofsky, C. J., Ayyar, S., Deem, A. K., Chung, W.-H., Ira, G., & Malkova, A. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.041 · Cited by 145
Ogi, T., Kato, T., Kato, T., & Ohmori, H. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00289.x · Cited by 141
Regulation of Rev1 by the Fanconi anemia core complex
Kim, H., Yang, K., Dejsuphong, D., & D'Andrea, A. D. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2222 · Cited by 137
DNA polymerase κ deficiency does not affect somatic hypermutation in mice
Schenten, D., Gerlach, V. L., Guo, C., Velasco-Miguel, S., Hladik, C. L., White, C., Friedberg, E. C., Rajewsky, K., & Esposito, G. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3152::aid-immu3152>3.0.co;2-2 · Cited by 137 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundO‐Wang, J., Kawamura, K., Tada, Y., Ohmori, H., Kimura, H., Sakiyama, S., & Tagawa, M. (2001) · PubMed · Cited by 136
Role for DNA Polymerase κ in the Processing of N2-N2-Guanine Interstrand Cross-links
Minko, I. G., Harbut, M. B., Kozekov, I. D., Kozekova, A., Jakobs, P. M., Olson, S. B., Moses, R. E., Harris, T. M., Rizzo, C. J., & Lloyd, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801238200 · Cited by 134
Role of DNA Polymerase η in the UV Mutation Spectrum in Human Cells
Stary, A., Kannouche, P., Lehmann, A. R., & Sarasin, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211838200 · Cited by 128
Ziv, O., Geacintov, N., Nakajima, S., Yasui, A., & Livneh, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812548106 · Cited by 122
Wang, Y., Woodgate, R., McManus, T. P., Mead, S., McCormick, J. J., & Maher, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3073 · Cited by 120 · cited 2×
“therefore susceptible to UV radiation-induced cancers because the cognate UV-induced cyclobutane pyrimidine dimers are instead bypassed by alternate TLS polymerases (POL ι and POL κ) in a relatively error-prone manner [11, 12].”
BackgroundYang, J., Chen, Z., Liu, Y., Hickey, R. J., & Malkas, L. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0603 · Cited by 117 · cited 1×
“Polι mice cells not sensitive to DNA damaging agents [57] • Elevated expression in breast cancer cells [58] • Important candidate for lung neoplasia [59] • Overexpressed in bladder cancer and in esophageal squamous cell carcinoma [60–62] • POLI SNP (rs8305) correlated with significant high risk of both lung adenocarci…”
BackgroundRey, L., Sidorova, J. M., Puget, N., Boudsocq, F., Biard, D. S. F., Monnat, R. J., Cazaux, C., & Hoffmann, J.-S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00115-09 · Cited by 114
Wojtaszek, J., Lee, C.-J., D'Souza, S., Minesinger, B., Kim, H., D'Andrea, A. D., Walker, G. C., & Zhou, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394841 · Cited by 111
Self-citationOhkumo, T., Kondo, Y., Yokoi, M., Tsukamoto, T., Yamada, A., Sugimoto, T., Kanao, R., Higashi, Y., Kondoh, H., Tatematsu, M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01076-06 · Cited by 110 · cited 1×
“Polι mice cells not sensitive to DNA damaging agents [57] • Elevated expression in breast cancer cells [58] • Important candidate for lung neoplasia [59] • Overexpressed in bladder cancer and in esophageal squamous cell carcinoma [60–62] • POLI SNP (rs8305) correlated with significant high risk of both lung adenocarci…”
BackgroundMohni, K. N., Thompson, P. S., Luzwick, J. W., Glick, G. G., Pendleton, C. S., Lehmann, B. D., Pietenpol, J. A., & Cortez, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125482 · Cited by 108
Dumstorf, C. A., Clark, A. B., Lin, Q., Kissling, G. E., Yuan, T., Kucherlapati, R., McGregor, W. G., & Kunkel, T. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605247103 · Cited by 105 · cited 1×
“Inefficiently bypasses UV damage in the absence of POL η [11, 55] • High protein expression in parathyroid, thyroid, reproductive organs and pituitary (http://www.”
BackgroundSeparate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells
Jansen, J. G., Tsaalbi-Shtylik, A., Hendriks, G., Gali, H., Hendel, A., Johansson, F., Erixon, K., Livneh, Z., Mullenders, L. H. F., Haracska, L., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00071-09 · Cited by 99
Washington, M. T., Minko, I. G., Johnson, R. E., Haracska, L., Harris, T. M., Lloyd, R. S., Prakash, S., & Prakash, L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6900-6906.2004 · Cited by 98 · cited 1×
“REV1 (REV1) Y-family • Exclusively inserts dCMPs opposite template Gs, abasic sites, and adducted G residues [13, 14] • Acts as a scaffolding protein by interacting with both POL ζ and RIR containing POL η, POL κ and POL ι [15, 16] • Generates G/C substitutions during Ig gene somatic hypermutation [17] • Accumulates i…”
BackgroundIncreased Susceptibility to UV-Induced Skin Carcinogenesis in Polymerase η–deficient Mice
Lin, Q., Clark, A. B., McCulloch, S. D., Yuan, T., Bronson, R. T., Kunkel, T. A., & Kucherlapati, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1862 · Cited by 95 · cited 1×
“org/home/gene/ POLH) • Polh (Pol η deficient; fertile, viable, but susceptible to skin cancers, mirrors XP-V phenotype, UV irradiated cells prone to chromatid breaks) [35–37] • Polh (slightly susceptible to UV radiation-induced skin carcinogenesis) [35] • Gene mutations causes XP-V [38] • High expression in single bas…”
BackgroundYeast DNA polymerase zeta (ζ) is essential for error-free replication past thymine glycol
Johnson, R. E., Yu, S.-L., Prakash, S., & Prakash, L. (2003) · Genes & Development · doi:10.1101/gad.1048303 · Cited by 95 · cited 1×
“POL ζ4 B-family (REV3 [REV3] polymerase, REV7 [REV7], POLD2 and POLD3 accessory subunits) [65] • POL ζ4 mediate inefficient TLS across CPDs, (6–4) photoproducts, adducted residues and AP sites, but an error free bypass of thymine glycols [53, 66, 67] • Serves as the key extender polymerase during TLS [68] • REV3 prote…”
BackgroundWang, H., Wu, W., Wang, H.-W., Wang, S., Chen, Y., Zhang, X., Yang, J., Zhao, S., Ding, H.-F., & Lu, D. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop074 · Cited by 93
Portraits of a Y‐family DNA polymerase
Yang, W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.047 · Cited by 92 · cited 1×
“Together, these structural attributes result in a larger and/or more permissive catalytic site than replicative polymerases that allows TLS polymerases to accommodate distorted and damaged nucleotides [81, 82].”
BackgroundBavoux, C., Leopoldino, A. M., Bergoglio, V., Wang, J. O., Ogi, T., Bieth, A., Judde, J., Pena, S. D. J., Poupon, M., Helleday, T., et al. (2005) · PubMed · Cited by 92
Involvement of Mouse Rev3 in Tolerance of Endogenous and Exogenous DNA Damage
Van Sloun, P. P. H., Varlet, I., Sonneveld, E., Boei, J. J. W. A., Romeijn, R. J., Eeken, J. C. J., & De Wind, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2159-2169.2002 · Cited by 89
Structure-dependent bypass of DNA interstrand crosslinks by translesion synthesis polymerases
Ho, T. V., Guainazzi, A., Derkunt, S. B., Enoiu, M., & Schärer, O. D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr448 · Cited by 86
The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis
Jansen, J. G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki189 · Cited by 85 · cited 1×
“org/home/gene/ REV1) • Rev1 (ΔBRCT region; accelerated skin cancers, genotoxininduced genome instability) [21, 22].”
Michiels, S., Danoy, P., Dessen, P., Bera, A., Boulet, T., Bouchardy, C., Lathrop, M. G., Sarasin, A. R., & Benhamou, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm111 · Cited by 81 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundBavoux, C., Leopoldino, A. M., Bergoglio, V., O-Wang, J., Ogi, T., Bieth, A., Judde, J.-G., Pena, S. D. J., Poupon, M.-F., Helleday, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.325.65.1 · Cited by 80 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundExpression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer
Rimkus, C., Friederichs, J., Rosenberg, R., Holzmann, B., Siewert, J., & Janssen, K. (2006) · International Journal of Cancer · doi:10.1002/ijc.22155 · Cited by 79
Multifaceted Recognition of Vertebrate Rev1 by Translesion Polymerases ζ and κ
Wojtaszek, J., Liu, J., D'Souza, S., Wang, S., Xue, Y., Walker, G. C., & Zhou, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380998 · Cited by 78
Self-citationPozhidaeva, A., Pustovalova, Y., D’Souza, S., Bezsonova, I., Walker, G. C., & Korzhnev, D. M. (2012) · Biochemistry · doi:10.1021/bi300566z · Cited by 76 · cited 1×
“Mutations that disrupt the RIR-interface in the Rev1 CTD prevent interaction with the inserter polymerase in yeast-2 hybrid (Y2H) screens [15, 16, 90, 91].”
BackgroundSelf-citationMammalian polymerase ζ is essential for post-replication repair of UV-induced DNA lesions
Jansen, J. G., Tsaalbi‐Shtylik, A., Hendriks, G., Verspuy, J. W. A., Gali, H., Haracska, L., & de Wind, N. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.09.006 · Cited by 71
Polk mutant mice have a spontaneous mutator phenotype
Stancel, J. N. K., McDaniel, L. D., Velasco, S., Richardson, J., Guo, C., & Friedberg, E. C. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.09.003 · Cited by 65 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundHuman REV1 Modulates the Cytotoxicity and Mutagenicity of Cisplatin in Human Ovarian Carcinoma Cells
Lin, X., Okuda, T., Trang, J., & Howell, S. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020446 · Cited by 62 · cited 1×
“org/ ENSG00000135945-REV1/cancer) • Responsible for drug resistance in ovarian cancer cells [26] • No known somatic mutations in cancers”
BackgroundPustovalova, Y., Magalhães, M. T. Q., D’Souza, S., Rizzo, A. A., Korza, G., Walker, G. C., & Korzhnev, D. M. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01282 · Cited by 61
Self-citationZhou, W., Chen, Y.-W., Liu, X., Chu, P., Loria, S., Wang, Y., Yen, Y., & Chou, K.-M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083978 · Cited by 60 · cited 1×
“org/ ENSG00000170734-POLH/cancer) • Enhanced expression in ovarian cancer stem cells [39] • Elevated levels in head and neck tumor samples [40] • 3 missense POLH mutations found amongst 201 melanoma patients [41]”
BackgroundTranslesion DNA synthesis in the context of cancer research
Knobel, P. A., & Marti, T. M. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-39 · Cited by 60
Suppression of REV 7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
Niimi, K., Murakumo, Y., Watanabe, N., Kato, T., Mii, S., Enomoto, A., Asai, M., Asai, N., Yamamoto, E., Kajiyama, H., et al. (2014) · Cancer Science · doi:10.1111/cas.12390 · Cited by 59 · cited 2×
“org/home/ gene/MAD2L) • Rev3 (Rev3 deficient; embryonically lethal and spontaneous and genotoxin induced genome instability) [69– 71] • Rev3Δlox (conditional Rev3 deficiency; reduced cell proliferation, spontaneous genomic instability and mice develop spontaneously mic lymphoma and spontaneous skin tumors) [72–74] • R…”
BackgroundDNA polymerase zeta is required for proliferation of normal mammalian cells
Lange, S. S., Wittschieben, J. P., & Wood, R. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks054 · Cited by 59
HENDEL, A., ZIV, O., GUERANGER, Q., GEACINTOV, N., & LIVNEH, Z. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.06.008 · Cited by 57
Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes
Luedeke, M., Linnert, C. M., Hofer, M. D., Surowy, H. M., Rinckleb, A. E., Hoegel, J., Kuefer, R., Rubin, M. A., Vogel, W., & Maier, C. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0772 · Cited by 56 · cited 1×
“Polι mice cells not sensitive to DNA damaging agents [57] • Elevated expression in breast cancer cells [58] • Important candidate for lung neoplasia [59] • Overexpressed in bladder cancer and in esophageal squamous cell carcinoma [60–62] • POLI SNP (rs8305) correlated with significant high risk of both lung adenocarci…”
BackgroundThe REV7 Subunit of DNA Polymerase ζ Is Essential for Primordial Germ Cell Maintenance in the Mouse
Watanabe, N., Mii, S., Asai, N., Asai, M., Niimi, K., Ushida, K., Kato, T., Enomoto, A., Ishii, H., Takahashi, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421966 · Cited by 55 · cited 1×
“org/home/ gene/MAD2L) • Rev3 (Rev3 deficient; embryonically lethal and spontaneous and genotoxin induced genome instability) [69– 71] • Rev3Δlox (conditional Rev3 deficiency; reduced cell proliferation, spontaneous genomic instability and mice develop spontaneously mic lymphoma and spontaneous skin tumors) [72–74] • R…”
BackgroundREV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells
Yang, L., Shi, T., Liu, F., Ren, C., Wang, Z., Li, Y.-Y., Tu, X., Yang, G. S., & Cheng, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120334 · Cited by 55
Masuda, K., Ouchida, R., Li, Y., Gao, X., Mori, H., & Wang, J.-Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901240 · Cited by 52 · cited 1×
“• Rev1 (defective Rev1 catalytic domain; reduced somatic hypermutation) [23].”
Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses
Lange, S. S., Bedford, E., Reh, S., Wittschieben, J. P., Carbajal, S., Kusewitt, D. F., DiGiovanni, J., & Wood, R. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217425110 · Cited by 51
Genetic linkage between Polι deficiency and increased susceptibility to lung tumors in mice
Lee, G., & Matsushita, H. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00042.x · Cited by 51 · cited 1×
“org/home/gene/ POLI) Poli (Pol ι deficient; mice susceptible to damage-induced lung tumors) [56].”
BackgroundWang, M., Devereux, T. R., Vikis, H. G., McCulloch, S. D., Holliday, W., Anna, C., Wang, Y., Bebenek, K., Kunkel, T. A., Guan, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3080 · Cited by 50 · cited 1×
“Polι mice cells not sensitive to DNA damaging agents [57] • Elevated expression in breast cancer cells [58] • Important candidate for lung neoplasia [59] • Overexpressed in bladder cancer and in esophageal squamous cell carcinoma [60–62] • POLI SNP (rs8305) correlated with significant high risk of both lung adenocarci…”
BackgroundVariants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk
Lucca, J. D., Guedj, M., Lacapère, J.-J., Fargnoli, M. C., Bourillon, A., Dieudé, P., Dupin, N., Wolkenstein, P., Aegerter, P., Saïag, P., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.034 · Cited by 47
Overexpression of DNA polymerase iota ( Polι ) in esophageal squamous cell carcinoma
Zhou, J., Zhang, S., Xie, L., Liu, P., Xie, F., Wu, J., Cao, J., & Ding, W. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02309.x · Cited by 45
REV1 Is Implicated in the Development of Carcinogen-Induced Lung Cancer
Dumstorf, C. A., Mukhopadhyay, S., Krishnan, E., Haribabu, B., & McGregor, W. G. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0399 · Cited by 43 · cited 1×
“• Rev1 (Rev1 deficient; near-infertile and unstable genome) [24] • Several hepatocarcinomas and occasional lung cancers show high expression of REV1 [25] (http:// www.”
BackgroundMizushina, Y., Motoshima, H., Yamaguchi, Y., Takeuchi, T., Hirano, K., Sugawara, F., & Yoshida, H. (2009) · Marine Drugs · doi:10.3390/md7040624 · Cited by 42
Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction
Actis, M. L., Ambaye, N. D., Evison, B. J., Shao, Y., Vanarotti, M., Inoue, A., McDonald, E. T., Kikuchi, S., Heath, R., Hara, K., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.026 · Cited by 42
Chun, A. C. S., Kok, K., & Jin, D. (2013) · Cell Cycle · doi:10.4161/cc.23214 · Cited by 42
Yuan, F., Xu, Z., Yang, M., Wei, Q., Zhang, Y., Yu, J., Zhi, Y., Liu, Y., Chen, Z., & Yang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069317 · Cited by 41
Wang, Y., Seimiya, M., Kawamura, K., Yu, L., Ogi, T., Takenaga, K., Shishikura, T., Nakagawara, A., Sakiyama, S., Tagawa, M., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.1.161 · Cited by 38 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundWang, J. O., Kajiwara, K., Kawamura, K., Kimura, M., Miyagishima, H., Koseki, H., & Tagawa, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00341-8 · Cited by 38
Solution structure of the mouse Rev1 C-terminal domain
Liu, J., Wojtaszek, J. L., & Zhou, P. (2012) · Worldwide Protein Data Bank · doi:10.2210/pdb2lsg/pdb · Cited by 37 · cited 6×
“The significance of the TLS process to human health is illustrated by xeroderma pigmentosum-variant patients, who are deficient in POL η and are PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006842 August 17, 2017 2 / 16 https://doi.org/10.1371/journal.pgen.1006842.g001 PLOS Genetics | https://doi.org/10.1371/…”
BackgroundInfluentialKrijger, P. H. L., Tsaalbi‐Shtylik, A., Wit, N., van den Berk, P. C. M., de Wind, N., & Jacobs, H. (2013) · European Journal of Immunology · doi:10.1002/eji.201243191 · Cited by 36 · cited 1×
“• Rev1 (Rev1 deficient; near-infertile and unstable genome) [24] • Several hepatocarcinomas and occasional lung cancers show high expression of REV1 [25] (http:// www.”
BackgroundA Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase κ
Yamanaka, K., Dorjsuren, D., Eoff, R. L., Egli, M., Maloney, D. J., Jadhav, A., Simeonov, A., & Lloyd, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045032 · Cited by 35
Self-citationREV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells
Wang, W., Sheng, W., Yu, C., Cao, J., Zhou, J., Wu, J., Zhang, H., & Zhang, S. (2015) · Oncology Reports · doi:10.3892/or.2015.4121 · Cited by 35
Mukhopadhyay, S., Clark, D. R., Watson, N. B., Zacharias, W., & McGregor, W. G. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh903 · Cited by 33
DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma
Zou, S., Shang, Z., Liu, B., Zhang, S., Wu, J., Huang, M., Ding, W., & Zhou, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8580 · Cited by 31
Replication Bypass of N2-Deoxyguanosine Interstrand Cross-Links by Human DNA Polymerases η and ι
Klug, A., Harbut, M. B., Lloyd, R. S., & Minko, I. G. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300011w · Cited by 29
Choi, J., Lim, S., Eoff, R. L., & Guengerich, F. P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.023 · Cited by 29 · cited 1×
“POL ι (POLI) Y-family • Efficiently bypasses template dA; but does so inefficiently on the template dT [52, 53] • Briefly accumulates in replication stress foci [54] • Back-up polymerase in the absence of POL η.”
BackgroundSale, J. E., Batters, C., Edmunds, C. E., Phillips, L. G., Simpson, L. J., & Szüts, D. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0197 · Cited by 28 · cited 1×
“Apart from bypassing DNA damage at stalled replication forks, TLS polymerases also engage in filling single stranded (ss) DNA gaps left behind by replicative polymerases, via the less-well understood gap-filling mechanism [92, 93].”
BackgroundTsaalbi‐Shtylik, A., Verspuy, J. W. A., Jansen, J. G., Rebel, H. G., Carlée, L., van der Valk, M. A., Jonkers, J., de Gruijl, F. R., & de Wind, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909507106 · Cited by 28 · cited 1×
“org/home/gene/ REV1) • Rev1 (ΔBRCT region; accelerated skin cancers, genotoxininduced genome instability) [21, 22].”
Efficiency, Fidelity and Enzymatic Switching DurinG Translesion DNA Synthesis
McCulloch, S. D., Kokoska, R. J., & Kunkel, T. A. (2004) · Cell Cycle · doi:10.4161/cc.3.5.893 · Cited by 27
Solovjeva, L., Svetlova, M., Sasina, L., Tanaka, K., Saijo, M., Nazarov, I. B., Bradbury, M., & Tomilin, N. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1066 · Cited by 25 · cited 1×
“POL η (POLH) Y-family • Bypasses T-T CPD and cisplatin-GG efficiently, but inefficiently across adducted residues, AP sites, 8-oxo-G [27–32] • Accumulates at DNA damage foci [20, 33].”
BackgroundOkina, S., Yanagisawa, N., Yokoyama, M., Sakurai, Y., Numata, Y., Umezawa, A., Higashihara, M., & Murakumo, Y. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1880-3 · Cited by 25
Klarer, A. C., Stallons, L. J., Burke, T. J., Skaggs, R. L., & McGregor, W. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039596 · Cited by 22
Ito, W., Yokoi, M., Sakayoshi, N., Sakurai, Y., Akagi, J., Mitani, H., & Hanaoka, F. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01576.x · Cited by 19
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress
Kotov, I. N., Olst, E. S., Knobel, P. A., van der Meulen‐Muileman, I. H., Felley‐Bosco, E., van Beusechem, V. W., Smit, E. F., Stahel, R. A., & Marti, T. M. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.008 · Cited by 14
PCR-free method detects high frequency of genomic instability in prostate cancer
Makridakis, N. M., Phipps, T. J., Srivastav, S. K., & Reichardt, J. K. V. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp761 · Cited by 8 · cited 1×
“org/home/gene/POLK) Polk (Pol κ deficient; fertile, cells are UV sensitive, spontaneous mutator phenotype in kidneys, liver and lungs, and the mice has shortened survival than Polk and Polk mice) [45, 46] • Elevated expression in lung cancer [47, 48] • Ectopic overexpression of POL κ induces aneuploidy and carcinogene…”
BackgroundZhang, X., Chen, Q., Chen, J., Chun-ya, H., Mao, J., Dai, Y., Yang, X., Hu, W., Zhu, C., & Chen, B. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24103 · Cited by 5
Translesion DNA Synthesis and Damage Tolerance Pathways
Masuda, Y., Hanaoka, F., & Masutani, C. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_11 · Cited by 4 · cited 1×
“POL ζ4 B-family (REV3 [REV3] polymerase, REV7 [REV7], POLD2 and POLD3 accessory subunits) [65] • POL ζ4 mediate inefficient TLS across CPDs, (6–4) photoproducts, adducted residues and AP sites, but an error free bypass of thymine glycols [53, 66, 67] • Serves as the key extender polymerase during TLS [68] • REV3 prote…”
Background
Cited by
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Bukowski, K., Kciuk, M., & Kontek, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093233 · Cited by 1,757
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
“DNA lesions, single strand breaks (SSB) and double strand breaks (DSB), are repaired by different DDR pathways including BER, NER, mismatch repair (MMR), homologous recombination (HR), non-homologous end joining (NHEJ), translesion synthesis (TLS) and Fanconi anemia (FA) pathway (Bellon et al., 1991; Tian et al., 2015…”
BackgroundDNA repair pathways and cisplatin resistance: an intimate relationship
Rocha, C. R. R., Silva, M. M., Quinet, A., Cabral-Neto, J. B., & Menck, C. F. M. (2018) · Clinics · doi:10.6061/clinics/2018/e478s · Cited by 446
A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
Wojtaszek, J. L., Chatterjee, N., Najeeb, J., Ramos, A., Lee, M., Bian, K., Xue, J. Y., Fenton, B. A., Park, H., Li, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.028 · Cited by 194
Self-citationTaglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J.-W., Wu-Baer, F., Baer, R., Costanzo, V., & Ciccia, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.016 · Cited by 173
Metadata
- Authors
- Yamanaka, K., Chatterjee, N., Hemann, M. T., & Walker, G. C.
- Affiliations
- Massachusetts Institute of Technology (US)
- Corresponding author
- Walker, Graham C.
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-08-17
- Volume
- 13
- Issue
- 8
- Pages
- e1006842
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC5560539
- OpenAlex
- W2747521922
- Cited by
- 87
- References
- 120
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 13 · 2020: 12 · 2019: 11 · 2018: 5 · 2017: 1
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- PLoS eBooks
- Funders
- National Institute of Environmental Health Sciences (ES-002109, ES-015818, P30ES002109, R56ES015818, R01ES015818)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- translesion synthesis, chemoresistance, acquired drug resistance, intrinsic drug resistance, Rev1, Y-family DNA polymerases, DNA damage, chemotherapy, adjuvant therapy, protein-protein interfaces
- MeSH terms
- Animals, Antineoplastic Agents, DNA Damage, DNA-Directed DNA Polymerase, DNA Repair, DNA Replication, Humans, Drug Resistance, Neoplasm, Nucleic Acid Synthesis Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.